Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplant

Authors

  • Maria Kalafateli The Royal Free Sheila Sherlock Liver Centre and Division of Surgery & Interventional Sciences, University College London, UK
  • Geoffrey Dusheiko The Royal Free Sheila Sherlock Liver Centre and Division of Surgery & Interventional Sciences, University College London, UK
  • Pinelopi Manousou The Royal Free Sheila Sherlock Liver Centre and Division of Surgery & Interventional Sciences, University College London, UK

Keywords:

.

Abstract

.

Downloads

Published

2015-06-01

How to Cite

1.
Kalafateli M, Dusheiko G, Manousou P. Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplant. JGLD [Internet]. 2015 Jun. 1 [cited 2025 Jun. 15];24(2):257-0. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/1230

Issue

Vol. 24 No. 2: June 2015

Section

Letters